Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

From 2 January 2023, Professor Peter Magill will lead the Medical Research Council Brain Network Dynamics Unit (MRC BNDU) at the University of Oxford.

Peter Magill

The MRC BNDU is one of the leading international research centres exploring neuronal dynamics in health and disease. The MRC BNDU at the University of Oxford aims to understand and exploit the moment-to-moment interactions between nerve cells that are critical for brain function, with a focus on brain circuits underlying movement and memory.

The unit's research spans clinical, experimental and computational neuroscience, as well as bioengineering, and works towards the collective goal of developing novel therapies for the correction of disturbed circuit interactions arising in disease.

Advance towards breakthrough interventions

Professor Magill commented:

'I am delighted to be appointed as Director of the MRC BNDU.

The MRC BNDU is a special community. The Unit is making unique contributions to the research and innovation ecosystem, stemming not only from the new knowledge and technologies it generates and shares but also by providing an outstanding environment for training, career development, and engaging the public with medical research.

I look forward to leading the MRC BNDU as we harness in-house expertise and our partnerships with wider academia and industry to advance towards breakthrough interventions that strategically interface with the brain for therapy in neurological and psychiatric disorders.'

About Professor Magill

Professor Magill has been an MRC Programme Leader since 2009, taking on the role of interim director for the MRC BDNU in January 2021. Professor Magill has led contiguous MRC-funded research programmes since 2009. He currently sits on both the MRC Neuroscience and Mental Health Board and the Training and Careers Group.

Professor Magill is internationally recognised for his research on the basal ganglia, a network of nerve cells lying deep within the brain that are important for purposeful actions. Peter's research contributions to improve understanding of basal ganglia has been of great value to improving understanding of wider brain circuitry function, particularly for patients with Parkinson's disease.

Professor Magill played a key role in the creation of the MRC BNDU, and was the unit's founding Deputy Director from 2015 until 2021. He then acted as Unit Interim Director, fostering sustained excellence and growth in the Unit's fundamental and translational research portfolios.


Read more on the Nuffield Department of Clinical Neurosciences website

Similar stories

RECOVERY trial team awarded MRC Impact Prize for Outstanding Team Impact

The Medical Research Council Prize Committee has awarded the RECOVERY trial team the MRC Impact Prize 2022 for Outstanding Team Impact.

Professor Sir Chris Whitty brings greater understanding of epidemics to Oxford

Chief Medical Officer of England Professor Sir Chris Whitty KCB FMedSci delivers the Sherrington Prize Lecture: Public Understanding of Science to an audience of Oxford staff and students.

Multiple Debilitating Pains – New global study shows the experience of Endometriosis is rooted in a person’s genetics

Researchers at the University of Oxford in collaboration with 25 teams across the world have published the largest study to date of the genetic basis of endometriosis.

Study shows delaying treatment for localised prostate cancer does not increase mortality risk

Active monitoring of prostate cancer has the same high survival rates after 15 years as radiotherapy or surgery, reports the largest study of its kind.

Showcasing Oxford’s translational research for Rare Disease Day

Rare Disease Day is an annual awareness day that aims to educate and raise awareness for the 400 million people worldwide who live with a rare disease.

Prostate cancer AI diagnosis tool begins evaluation in Oxford

New artificial intelligence software that can help to spot prostate cancer is being trialled by researchers at Oxford University Hospitals (OUH) NHS Foundation Trust.